Article Type

1 - 15 of 60 Results       Clear All

Study Suggests Children Are Breathing CO2 When Wearing Masks, Experts Say Levels Are Not Dangerous

Gladstone in the News July 6, 2021

Study Suggests Children Are Breathing CO2 When Wearing Masks, Experts Say Levels Are Not Dangerous

ABC7 News—A new study shows that wearing a mask increases slightly the amount of carbon dioxide children breathe. Gladstone President Deepak Srivastava, MD, cautions that the study was small, the increase in carbon dioxide is not known to be dangerous, and that wearing a mask and getting vaccinated remain the best protections against COVID-19.

COVID-19 Cardiovascular Disease Srivastava Lab

San Francisco Researchers Use Genetic Clues to Identify Possible Drug for Treating Heart Conditions

Gladstone in the News February 3, 2021

San Francisco Researchers Use Genetic Clues to Identify Possible Drug for Treating Heart Conditions

ABC7 News—Gladstone President Deepak Srivastava, MD, a pediatric cardiologist, explains how his group discovered a potential new drug to treat a debilitating disease due to the hardening of heart valves.

Gladstone Experts Congenital Heart Disease Cardiovascular Disease Srivastava Lab Stem Cells/iPSCs

California Prop 14 May Change Lives of Sick Kids, Keep Taxpayer Funding of Stem Cell Therapy Research

Gladstone in the News November 2, 2020

California Prop 14 May Change Lives of Sick Kids, Keep Taxpayer Funding of Stem Cell Therapy Research

USA Today—California Proposition 14 put funding for the Stem Cell Research Institute on the ballot this year. Gladstone President Deepak Srivastava, MD, explains how previous funding for stem cell research in California has helped bring the field to a point where stem cell–based therapies are now possible.

Gladstone Experts Cardiovascular Disease Srivastava Lab Stem Cells/iPSCs

Trump’s COVID-19 Treatment Developed Using Cells Originally Drawn from Fetal Tissue

Gladstone in the News October 14, 2020

Trump’s COVID-19 Treatment Developed Using Cells Originally Drawn from Fetal Tissue

abc News—Gladstone President Deepak Srivastava, MD, comments on the fact that the experimental treatments President Trump received for COVID-19 were tested on cells that were derived from fetal tissue decades ago, and expresses concern that the Trump administration's current ban on the use of fetal tissue for research could slow efforts to curb the pandemic.

Gladstone Experts COVID-19 Cardiovascular Disease Srivastava Lab

Trump’s Covid Treatments Were Tested in Cells Derived From Fetal Tissue

Gladstone in the News October 8, 2020

Trump’s Covid Treatments Were Tested in Cells Derived From Fetal Tissue

The New York Times—The experimental drugs used to treat President Trump for COVID-19 were developed with the help of a human cell line derived from a fetus aborted decades ago. Gladstone President Deepak Srivastava, MD, and Senior Investigator Warner Greene, MD, PhD, comment on the ethics of accepting this treatment while also banning research using newly derived fetal cells, in the process thwarting the development of life-saving treatments for other conditions.

Gladstone Experts COVID-19 Cardiovascular Disease Center for HIV Cure Research Greene Lab Srivastava Lab

More News

Are You a Journalist Looking to Write about Gladstone?

Explore Info for Media